Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Caribou Biosciences (CRBU) has provided an update.
Jason O’Byrne, CFO of Caribou Biosciences, is set to resign on September 27, 2024, to explore a new opportunity, leaving his dual role as the principal financial and accounting officer. His departure is amicable, with no disputes over financial matters. The company is actively seeking a new CFO, while Ryan Fischesser, currently Vice President of Finance and Controller, is slated to take over as the principal accounting officer. Fischesser brings a background in finance from co-founding BHLF LLP and a history with Caribou since 2017.
For a thorough assessment of CRBU stock, go to TipRanks’ Stock Analysis page.